Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy
The Lupus Research Alliance (LRA) announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The...
Search Results
You searched for: lupus nephritis
Results found: 173
Lupus Research Alliance Announces Four New Recipients of the Lupus Mechanisms and Targets Award
Winning projects will explore new potential treatment approaches to prevent lupus from developing or prevent or slow disease progression....
Lupus Research Alliance Announces Recipients of 2023 Diversity in Lupus Research Awards
NEW YORK, NY, July 12, 2023 — The Lupus Research Alliance is pleased to announce the 2023 recipients of...
Lupus Research Alliance Announces Recipients of 2024 Diversity in Lupus Research Awards
The Lupus Research Alliance (LRA) is pleased to announce the recipients of the 2024 Career Development and Postdoctoral Awards...
LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results from...
How Are the New Lupus Nephritis Guidelines Impacting Treatment?
Perspective by renowned nephrologist Dr. Brad Rovin Recognized as National Kidney Month, March is the ideal time to learn more...
LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA
NEW YORK, NY. July 22, 2020. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA...
Low-Dose Chemotherapy May Help Lupus Nephritis
February 22, 2021
In a recent study published in Arthritis & Rheumatology, LRA-funded researcher Dr. Xian Zhang found that a...
LRA Highlights Groundbreaking Lupus Research at ACR Convergence 2023
This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
NEW YORK, NY. January...